Thomas Theriault
Gründer bei Bullet Biotechnology, Inc.
Aktive Positionen von Thomas Theriault
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Bullet Biotechnology, Inc.
 Bullet Biotechnology, Inc. BiotechnologyHealth Technology Bullet Biotechnology, Inc. develops active immunotherapies to stimulate a person’s own immune system to overcome diseases. Its technology educates the immune system to targeting specific cells that are causing disease. The firm's pipeline includes therapeutic vaccines for cancer, multi-specific antibody capsid products, therapeutic vaccines for autoimmune diseases, and other vaccines. The company was founded by Diego Fonstad, James R. Swartz, Willie Quinn and Thomas Theriault in September 2011 and is headquartered in Redwood City, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2011 | - |
| Gründer | 01.09.2011 | - |
Karriereverlauf von Thomas Theriault
Ehemalige bekannte Positionen von Thomas Theriault
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GENITOPE CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2005 | 31.03.2008 |
| INCYTE CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.08.1996 | 01.04.2004 |
Combion, Inc.
 Combion, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Incyte Corp., Combion, Inc. is a company that develops ink-jet technology for a variety of high-density gridding synthesis applications. The company is based in Pasadena, CA. The company was founded by Thomas Theriault, John D. Baldeschwieler. Combion was acquired by Incyte Corp. on August 15, 1996 for $2.98 million. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1996 | 01.01.1996 |
| Gründer | 01.01.1996 | 01.01.1996 |
Ausbildung von Thomas Theriault
| Dartmouth College | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Genitope Corp.
 Genitope Corp. BiotechnologyHealth Technology Genitope Corp. operates as a biotechnology company, which focuses on the research and development of novel immunotherapies for the treatment of cancer. The company was founded on August 15, 1996 and is headquartered in Redwood, CA. | Health Technology |
Combion, Inc.
Combion, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Incyte Corp., Combion, Inc. is a company that develops ink-jet technology for a variety of high-density gridding synthesis applications. The company is based in Pasadena, CA. The company was founded by Thomas Theriault, John D. Baldeschwieler. Combion was acquired by Incyte Corp. on August 15, 1996 for $2.98 million. | Commercial Services |
Bullet Biotechnology, Inc.
Bullet Biotechnology, Inc. BiotechnologyHealth Technology Bullet Biotechnology, Inc. develops active immunotherapies to stimulate a person’s own immune system to overcome diseases. Its technology educates the immune system to targeting specific cells that are causing disease. The firm's pipeline includes therapeutic vaccines for cancer, multi-specific antibody capsid products, therapeutic vaccines for autoimmune diseases, and other vaccines. The company was founded by Diego Fonstad, James R. Swartz, Willie Quinn and Thomas Theriault in September 2011 and is headquartered in Redwood City, CA. | Health Technology |
- Börse
- Insiders
- Thomas Theriault
- Erfahrung
